UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Stokes Family Office LLC

Stokes Family Office LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,732 shares of the healthcare conglomerate’s stock after selling 39 shares during the quarter. Stokes Family Office LLC’s holdings in UnitedHealth Group were worth $1,888,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in UNH. Howard Capital Management Group LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $341,000. Principal Financial Group Inc. lifted its holdings in UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after purchasing an additional 180,479 shares during the period. Baron Wealth Management LLC increased its stake in UnitedHealth Group by 32.1% during the 3rd quarter. Baron Wealth Management LLC now owns 1,923 shares of the healthcare conglomerate’s stock valued at $1,124,000 after buying an additional 467 shares during the period. Lindenwold Advisors INC lifted its position in UnitedHealth Group by 0.4% in the third quarter. Lindenwold Advisors INC now owns 8,907 shares of the healthcare conglomerate’s stock worth $5,208,000 after purchasing an additional 37 shares during the period. Finally, Pathstone Holdings LLC boosted its position in shares of UnitedHealth Group by 0.9% during the 3rd quarter. Pathstone Holdings LLC now owns 153,486 shares of the healthcare conglomerate’s stock valued at $89,731,000 after purchasing an additional 1,388 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 0.9 %

Shares of UnitedHealth Group stock opened at $503.61 on Wednesday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The stock has a market capitalization of $460.66 billion, a P/E ratio of 32.49, a PEG ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a 50 day moving average price of $510.90 and a two-hundred day moving average price of $548.54.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.83 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.67%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is currently owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.